focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Jim Short expects to serve 50,000 patients when phase two is up and running and that will give CEL a turnover of £90m with £52m profits. His ambition is by 2027 to serve one million patients which will produce over £1 billion of profits. That is without profits from LVL. By my reckoning that is over £500 a share. Can someone do the maths please?
Am I right in thinking James Short owns 50% of the shares in issue?
So unless I am mistaken, Celadon are now one of the few companies with a licence to sell this product? So, based on that, would it be unreasonable to be expecting sales news in the near future? I only ask as I noticed the small sell off yesterday and wonder if I have missed anything
When I closed a position in next few days will buy in gla
A little Fomo in the other cannabis related stocks they will flood back to this massive premium quality stock. The news is massive and has opened the flood gates to make some serious green
BS at £90m sales they make £45m EBIT on a pe of 15x that makes a market cap of £675m, so 63m shares gives an initial target price of £10.71 Thats before international expansion or a US bid. Time to top up imho.
-)) I've a feeling the next will be better attended.
Yes, saw the rns drop and will stick with this share over the next few years I expect.
The big draw will be an eventual NY listing.
That's funny .I was also at the AGM and the hall was almost empty.
They got the HO full license today.
I have followed this share a while and attended the AGM.
DYOR but my notes from that AGM were that:
The current facility can produce product for 50,000 patients.
In the Uk alone there are 3 million patients who may be eligible for a cannabiniod remedy.
At full capacity the facility can grow 10 to 15 tonnes of product a year and that could equal £90m annual revenue.
Companies in this space (pharmaceutical not cannabinoid - don't make that mistake ) trade on typically greater than 14* ebitda.
Factor in the 63m share float and you get the picture.
I see no reason why this therefore cannot emulate GWP and the management have demonstrated that they can execute.
Massive rns!!!
£3 by friday.
This news is mental and a huge game changer
only one in a few have the license globally anyone know their competitors and the mcap the are at will give a rough idea where this is going let me check too
HUGE NEWS
Sleeping Giant waking up £2 by Friday nailed maybe even tomorrow
Home office licence and form of sales will send this rocketing.
My expectation is double the IPO price so looking for 330p which seems reasonable after progress made.
Out.
good luck hope it goes higher
Excellent day today. GLA
I never exspected this kind of rise before the Home Office Licence anouncment. Low share float and potential blue sky company being the first in the uk to be able to grow high THC medical cannabis. What’s your target because mine is way about 88p.
This has classic Friday pump and dump, why the rise ? Will close < 75
Can't get a quote just now
The disappointed IPO sellers may have sold out leaving only those for the long haul.